| Naslov: | Obstructive urination problems after high-dose-rate brachytherapy boost treatment for prostate cancer are avoidable |
|---|
| Avtorji: | ID Kragelj, Borut (Avtor) |
|---|
| Datoteke: |  URL - Izvorni URL, za dostop obiščite http://www.degruyter.com/view/j/raon.2016.50.issue-1/raon-2015-0010/raon-2015-0010.xml?format=INT
 PDF - Predstavitvena datoteka, prenos (537,29 KB)
MD5: DA2C2AAC9BB646D77DF539E3F0EF3785
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: |  OI - Onkološki inštitut Ljubljana
|
|---|
| Povzetek: | Aiming at improving treatment individualization in patients with prostate cancer treated with combination of external beam radiotherapy and high-dose-rate brachytherapy to boost the dose to prostate (HDRB-B), the objective was to evaluate factors that have potential impact on obstructive urination problems (OUP) after HDRB-B. Patients and methods. In the follow-up study 88 patients consecutively treated with HDRB-B at the Institute of Oncology Ljubljana in the period 2006-2011 were included. The observed outcome was deterioration of OUP (DOUP) during the follow-up period longer than 1 year. Univariate and multivariate relationship analysis between DOUP and potential risk factors (treatment factors, patients% characteristics) was carried out by using binary logistic regression. ROC curve was constructed on predicted values and the area under the curve (AUC) calculated to assess the performance of the multivariate model. Results. Analysis was carried out on 71 patients who completed 3 years of follow-up. DOUP was noted in 13/71 (18.3%) of them. The results of multivariate analysis showed statistically significant relationship between DOUP and anticoagulation treatment (OR 4.86, 95% C.I. limits: 1.21-19.61, p = 0.026). Also minimal dose received by 90% of the urethra volume was close to statistical significance (OR = 1.23; 95% C.I. limits: 0.98-1.07, p = 0.099). The value of AUC was 0.755. Conclusions. The study emphasized the relationship between DOUP and anticoagulation treatment, and suggested the multivariate model with fair predictive performance. This model potentially enables a reduction of DOUP after HDRB-B. It supports the belief that further research should be focused on urethral sphincter as a critical structure for OUP. |
|---|
| Ključne besede: | prostate cancer, high-dose-rate brachytherapy boost, urinary stricture, obstructive urination problems |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Datum objave: | 01.03.2016 |
|---|
| Založnik: | Association of Radiology and Oncology |
|---|
| Leto izida: | 2016 |
|---|
| Št. strani: | str. 94-103, VII |
|---|
| Številčenje: | Vol. 50, no. 1 |
|---|
| Izvor: | Ljubljana |
|---|
| PID: | 20.500.12556/DiRROS-18858  |
|---|
| UDK: | 616.65-006-08 |
|---|
| ISSN pri članku: | 1318-2099 |
|---|
| DOI: | 10.1515/raon-2015-0010 |
|---|
| COBISS.SI-ID: | 2275707 |
|---|
| Avtorske pravice: | by Authors |
|---|
| Datum objave v DiRROS: | 30.04.2024 |
|---|
| Število ogledov: | 75 |
|---|
| Število prenosov: | 48 |
|---|
| Metapodatki: |     |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
